Absolutely, Mr. Buck, and I look forward to our ongoing discussion on that really critical issue.

Yesterday, I reintroduced the Affordable Prescriptions for Patients through Competition Act together with Subcommittee Ranking Member Buck and Senators Cornyn and Blumenthal.

In closing, the American people deserve a government that is in their corner fighting for them to take on drug profiteering and other barriers to affordable healthcare.

You can't just do that and expect these healthcare pharma issues to be taken care of without funding those agencies.

I also have worked on that bill with Senator Grassley.

I think that regulatory reform and competition advocacy are very, very important.

It would eliminate the abuses of product hopping.

both parties here are looking for effective public action to guarantee real market competition.

I am tremendously encouraged to see bipartisan efforts to address these critical needs and to help improve access to affordable prescription drugs for patients.

Have you adapted that for Zoom? I mean, we are adapting everything for Zoom.

Break them up. That is the remedy that I have advocated on some of the Big Tech companies.

Can we change that legislatively? Or is the clock going to run out as you come back to work?

Today, pharmaceutical companies are confronting the American people with a terrible choice: Miss rent payments and skip meals to pay for their prescriptions or go without the lifesaving medications that they need.

I am supportive of doing something. I am actually not against this bill, but I think it's a piecemeal approach.

I want to thank Senators Grassley, Cornyn, and Klobuchar, and Blumenthal for their work on these important issues.

It is unacceptable that people suffering from diabetes must worry about life-threatening consequences of not being able to afford insulin.

I think these are good initiatives. They're really a top-down, not bottom-up approach.

This is not true innovation, and it is costing hardworking Americans.